Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-050072
Filing Date
2024-04-22
Accepted
2024-04-22 17:15:40
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-22

Document Format Files

Seq Description Document Type Size
1 ARS vp_tm2412421d1ars.pdf ARS 2018546
  Complete submission text file 0001104659-24-050072.txt   2771710
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37368 | Film No.: 24862022
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)